Trademark search for:

MAXSERO

EXPIRED USPTO USPTO

USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2012-08-31 — Application filed
2012-10-11 — Sn assigned for sect 66a appl from ib
2012-10-12 — Application filed
2012-10-16 — Application filed
2012-10-22 — Approved for pub - principal register
2012-10-22 — Assigned to examiner
2012-11-07 — Notice of publication
2012-11-07 — Notification of possible opposition sent to ib
2012-11-07 — Notice of start of opposition period created, to be sent to ib
2012-11-26 — Notification processed by ib
2012-11-27 — Published for opposition
2013-02-12 — Registered-principal register
2013-03-14 — Grant of protection created, to be sent to ib
2013-03-22 — Final disposition recorded
2013-03-22 — Final disposition recorded
2013-04-28 — New representative at ib received
2013-04-28 — Notification processed by ib
2015-07-03 — Change of owner received from ib
2019-09-13 — Cancelled section 71
2020-05-13 — Total invalidation of reg ext protection created
2020-06-15 — Invalidation processed
2020-06-16 — Total invalidation of reg ext protection sent to ib
2020-07-17 — Total invalidation processed by the ib
2022-08-31 — Final status recorded
2023-03-27 — Death of international registration
2023-03-28 — Notification of effect of cancellation of intl reg mailed

Owner Information

Glaxosmithkline Biologicals S.A.
BE

Novartis AG
CH

Novartis AG
CH

Novartis AG
CH

Correspondent

Schneider Feldmann AG Patent- und Markenanwälte
Beethovenstrasse 49,
Postfach 2792
CH-8022 Zürich,

Filing Details

Filing Date:
2012-08-31

Status Date:
2022-08-31

Category:
Pharmaceuticals

Filing Year:
2012

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.